50 cancer, rare disease drugs to get cheaper
Wednesday, January 23, 2019, 1:01 PM
In a move to curtail profiteering on crucial medicines, the Centre is set to cap trade margins charged by drug retailers and stockists at around 25-30% for over 50 non-schedule medicines for cancer and rare diseases, which are currently exempted from price regulation, official sources said. The decision was taken at a high-level meeting with the Prime Minister's Office earlier this month.
Drugs regulator tells Johnson and Johnson to share ingredients
Wednesday, July 25, 2018, 5:55 PM
India's top drug regulator has asked J&J Pvt. Ltd to reveal the composition of its talcum powder, two people aware of the matter said. The company's US parent was ordered to pay $4.7 billion to 22 women who claimed asbestos in its talc had caused them ovarian cancer. Johnson and Johnson insists its talc is safe and pure, and plans to appeal the verdict.